Leading Titanium Dioxide Manufacturers Shaping the Future of Paints, Plastics, and Construction
The titanium dioxide market is projected to grow from USD 19.06 billion in 2025 to USD 35.35 billion by 2034, driven by its essential role as a white pigment and opacifier in various industries like paints, plastics, and construction. Fortune Business Insights highlights ten leading companies, including LB Group, Chemours Company, and Tronox Holdings, which are innovating and expanding production to meet increasing global demand, especially in the Asia-Pacific region. The article emphasizes that titanium dioxide's unique properties and widespread applications secure its long-term importance in diverse sectors.
The Chemours Co (CC) Shares Fall 3.7% -- What GF Score of 66 Tells Investors
The Chemours Co (CC) shares dropped 3.7% today, closing at $21.44, and are currently considered 8.4% overvalued according to GuruFocus's GF Value™. The stock has a GF Score™ of 66/100, indicating it is above average, but a low financial strength rating and a P/E ratio significantly higher than its historical median suggest potential risks for investors. There have been no insider transactions in the last three months, implying a neutral stance from company insiders.
Chemours makes case to top NC court for tossing AG Jackson’s lawsuit
Chemours and DuPont are petitioning the North Carolina Supreme Court to dismiss Attorney General Jeff Jackson's environmental contamination lawsuit, arguing it's a duplicative attempt to extract more money after a prior settlement with the NC Department of Environmental Quality. The companies contend that Jackson lacks the authority to pursue a second lawsuit for the same alleged harms already addressed by a binding consent order. The Supreme Court will hear oral arguments on September 15, with justices divided on the matter and significant debate over the Attorney General's common-law authority versus regulatory agency roles.
Chemours falls as EPA's rollback of refrigerant rule raises oversupply concerns (CC:NYSE)
Chemours (CC) shares fell by over 8% after the Environmental Protection Agency (EPA) announced plans to ease Biden-era refrigerant restrictions. Investors are concerned this rollback could weaken pricing power for newer, lower-emissions cooling chemicals, potentially leading to an oversupply and slowing the adoption of next-generation refrigerants. The revised rules are expected to save consumers and businesses over $2.4 billion, primarily through extended deadlines and broader refrigerant allowances.
Chemours (CC) Is Down 8.4% After Issuing 2026 Profit Guidance Amid Q1 Net Loss
Chemours (CC) recently reported a Q1 2026 net loss of US$29 million but issued new guidance projecting full-year 2026 net income between US$165 million and US$225 million. This guidance provides a clearer path to profitability for the company, although persistent concerns about PFAS litigation and the need for strong execution on this new guidance remain key challenges. Despite the improved earnings outlook, current analyst models project a 29% downside to Chemours' fair value.
Chemours Company (The) Common Stock (NY: CC
This article provides recent news headlines related to The Chemours Company (NYSE: CC), including its upcoming earnings report on May 03, and general market news from April 2021. It also lists the current stock price and performance for Chemours.
Chemours Titanium Technologies Earns Two Recognitions From the U.S. Department of Energy Better Buildings & Better Plants Initiative for Innovation in Energy and Materials Efficiency
Chemours Titanium Technologies received two awards from the U.S. Department of Energy's Better Buildings, Better Plants Initiative for its leadership in energy efficiency and sustainable manufacturing. The awards recognized a "Zero Capital Energy Savings Through Automation" project that reduced energy costs and waste, and an "Innovative Packaging Redesign" that cut waste and emissions through material circularity. These initiatives highlight Chemours' commitment to embedding sustainability into its operations, driving both environmental impact and financial performance.
Chemours CFO talks PFAS, tariffs and internal controls
Chemours CFO Shane Hostetter discusses the company's "Pathway to Thrive" strategy, aiming for $250 million in cost reductions by 2027 and forecasting an adjusted EBITDA of $800-$900 million for the year. He also addresses the resolution of PFAS-related environmental liabilities, the beneficial impact of tariffs on the company's Titanium Technologies business, and the steps taken to strengthen internal controls following a leadership shakeup. Hostetter emphasizes a culture of continuous improvement, including the adoption of automation and AI within the finance department.
New Industry Study, Identifies Path to Cut Cumulative Automotive Refrigerant Emissions Across Europe by ≈50% Between 2030-2050
A new industry study, co-led by The Chemours Company and Solstice Advanced Materials Inc., reveals a path to significantly cut refrigerant emissions from European automotive air conditioning systems. The research suggests that cumulative emissions could be reduced by approximately 50% between 2030 and 2050 through coordinated measures across the automotive value chain, including circular economy solutions like reclamation and recycling. These reductions are achievable and cost-neutral for consumers, offering comparable effectiveness across various vehicle types, including electric vehicles.
New Industry Study, Identifies Path to Cut Cumulative Automotive Refrigerant Emissions Across Europe by ≈50% Between 2030-2050
A new industry study co-led by The Chemours Company and Solstice Advanced Materials Inc. reveals that automotive refrigerant emissions in Europe could be reduced by over 60% annually by 2050, achieving an average 50% cumulative reduction between 2030 and 2050. This can be accomplished through coordinated measures across the automotive value chain, including reclamation and recycling, offering cost-neutral outcomes for consumers. The findings emphasize the importance of collaborative industry action and circular economy solutions for Europe's climate and sustainability goals.
Chemours Company (The) Stock 12‑Month Price Target Raised to $25.6, Implies 11% Upside
The 12-month price target for The Chemours Company (CC) stock has been raised from $25.2 to $25.6 by 10 analysts, implying an 11% potential upside based on the May 8 closing price. Forecasts range from $17 to $30 per share, and the consensus rating remains "Buy" from 12 covering analysts. This includes 6 Buys, 4 Holds, and 2 Sells.
RFG Advisory LLC Cuts Holdings in The Chemours Company $CC
RFG Advisory LLC significantly reduced its stake in The Chemours Company ($CC) by 47.7% in the fourth quarter, selling over 51,000 shares. Despite this, institutional ownership in Chemours remains high at 76.26%, and analysts maintain a cautious "Hold" rating with an average price target of $21.70, while the stock recently traded at $23.06 following a better-than-expected earnings report. The company also announced a quarterly dividend of $0.0875 per share.
UBS Group AG Has $42.27 Million Holdings in The Chemours Company $CC
UBS Group AG significantly reduced its stake in The Chemours Company (NYSE:CC) by 24.6% in the fourth quarter, selling 1,169,293 shares and ending with holdings valued at $42.27 million. Despite some analysts raising price targets, the consensus rating for Chemours remains a "Hold" with an average price target of $21.60. The specialty chemicals company recently reported an earnings beat for the quarter and announced a quarterly dividend.
Number of shareholders of Chemours Co. – DUS:2CU
The article, published on TradingView, provides a page specifically for Chemours Co. (DUS:2CU) financials, including general information and data fields for the number of shareholders. It highlights market data provided by ICE Data Services and FactSet, along with SEC filings from Quartr.
Chemours (NYSE: CC) director receives 7,182 stock units as board compensation
Chemours director Leslie M. Turner was granted 7,182 stock units of Chemours common stock on May 6, 2026, as part of routine equity-based board compensation. These units were awarded at no cash cost and increased her direct holdings to 24,603.3891 stock units. The stock units, which include deferred stock units and dividend equivalent units, will convert into common stock when Turner separates from service on the Board.
Chemours (NYSE: CC) director Courtney Mather granted 7,182 stock units
Chemours director Courtney Mather was granted 7,182 stock units on May 6, 2026, which will convert into common shares upon her separation from service on the Board. Following this award, Mather now holds a total of 21,642.7173 stock units. The grant was part of equity compensation and did not involve a cash payment from the director.
The Chemours Company Announces Completion of Euro denominated Term Loan Repricing
The Chemours Company announced the completion of its Euro-denominated term loan repricing. This news was released via a Quantisnow PR, a platform that aggregates market data and news for retail investors. The article also includes recent analyst ratings and details of insider stock grants for several directors of Chemours Company.
Chemours (NYSE: CC) director Erin Kane granted 7,182 stock units
Chemours (NYSE: CC) director Erin N. Kane was granted 7,182 stock units as board compensation, increasing her total holdings to 74,062.9086 units. These units, which will convert to common stock upon her separation from the board, were granted at $0.00 per unit and represent a routine, non-cash equity award rather than an open-market purchase. This insider transaction was reported on an SEC Form 4 filing.
Chemours (NYSE: CC) director granted 7,182 shares in equity award
Chemours (NYSE: CC) director George R. Brokaw was granted 7,182 shares of Common Stock on May 6, 2026, as an equity award with a reported price of $0.00 per share. This transaction increases his direct holdings, including deferred stock units and dividend equivalent units, to a total of 21,642.7173 shares. This Form 4 filing indicates compensation rather than a market purchase, and no derivative securities were involved.
Chemours director granted 7,182 company shares | CC Insider Trading
Chemours (NYSE: CC) director Mary B. Cranston received an equity grant of 7,182 common shares on May 6th, reflecting stock-based compensation. This award, granted at no cash cost, increases her total holdings to 106,830.0129 shares, including deferred stock units and dividend equivalent units, after an adjustment for a previous administrative error. The transaction was reported in a Form 4 filing, indicating an internal compensation event rather than an open-market purchase.
The Chemours Company Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts
The Chemours Company reported a surprise loss of US$0.19 per share and revenues of US$1.4 billion, missing analyst expectations for profit. Following these results, analysts have revised their 2026 EPS forecasts downwards, although revenue expectations remained stable. Despite the lowered earnings outlook, analysts increased their price target for Chemours, suggesting confidence in its long-term intrinsic value.
The Chemours Company Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts
The Chemours Company (NYSE:CC) saw its stock drop 17% after missing earnings expectations with a surprise statutory loss of US$0.19 per share, despite revenues of US$1.4 billion. Analysts have since revised their 2026 EPS estimates downwards, although revenue forecasts remained stable and the price target was increased by 9.8% to US$24.89, suggesting long-term optimism. The company's revenue growth is expected to accelerate, aligning with the overall industry's projected growth rate.
Research Alert: CFRA Keeps Sell On Shares Of The Chemours Company
This article states that CFRA has maintained a 'Sell' rating on shares of The Chemours Company, indicating a negative outlook on the stock's future performance. The alert suggests that CFRA analysts anticipate a decline in the company's stock value. This information is crucial for investors considering The Chemours Company.
The Chemours Company 2026 Q1 - Results - Earnings Call Presentation (NYSE:CC) 2026-05-07
This article provides details on The Chemours Company's (NYSE:CC) 2026 Q1 earnings call presentation. The company reported EPS of $0.05, beating estimates by $0.09, and revenue of $1.38 billion, which missed estimates by $17.97 million. The article highlights that the slide deck for the earnings call was published on May 7, 2026.
Chemours (CC) Q1 Loss Of US$29 Million Reinforces Bearish Profitability Concerns
Chemours (CC) reported a Q1 2026 loss of US$29 million with revenue of US$1.4 billion, reinforcing bearish concerns about its profitability. The company's trailing 12-month net loss stands at US$410 million, despite relatively steady revenues. Analysts and investors are scrutinizing margins and the company's slower revenue growth compared to the broader market, as well as balance sheet pressures and a low P/S multiple.
Earnings call transcript: Chemours Co Q1 2026 beats EPS forecast, stock falls
Chemours Co (NYSE: CC) reported Q1 2026 earnings, beating EPS forecasts with $0.05 against an expected -$0.04, while revenue met expectations at $1.4 billion. Despite the earnings beat, the stock fell 16.79% in premarket trading and closed at $23.25, possibly due to operational disruptions and overvaluation concerns, even though the company expects to be profitable this year. Chemours provided guidance for future quarters, projecting continued growth and emphasizing strategic execution, debt reduction, and operational efficiency through its "Pathway to Thrive" strategy.
Chemours Announces Second Quarter Dividend
The Chemours Company (NYSE: CC) announced that its Board of Directors declared a quarterly cash dividend of $0.0875 per share on the Company's common stock for the second quarter of 2026. The dividend is scheduled to be paid on June 16, 2026, to stockholders of record as of May 17, 2026. Chemours is a global leader in industrial and specialty chemicals, operating through three businesses.
Chemours Supplies Lower Global Warming Potential Refrigerant to Three Ice Rink Venues in Beijing
Chemours is supplying its Opteon™ XP40 refrigerant, which has a lower global warming potential, to three ice rink venues for the 2022 Winter Games in Beijing: the National Aquatics Center, National Indoor Stadium, and Wukesong Sports Centre. This selection aligns with Beijing's mission to adopt more sustainable solutions and reduces the global warming potential by approximately 65% compared to previous games. The Opteon™ XP40 refrigerant ensures stable and reliable ice performance while elevating sustainability and safety for athletes and spectators.
Chemours declines 13% after mixed quarter, flags higher financing costs
Chemours (CC) shares declined 13% after reporting a mixed Q1 2026 performance with a miss on revenue but a beat on adjusted EPS. The company maintained its 2026 adjusted EBITDA outlook but lowered its adjusted EPS forecast, citing higher estimated financing costs. Despite some positive operational improvements, the market reacted negatively to the revised earnings guidance and increased financial obligations.
Full Transcript: Chemours Q1 2026 Earnings Call
Chemours reported strong Q1 2026 results, exceeding earnings expectations with standout performances in Thermal & Specialized Solutions (TSS) and Titanium Technologies (TT) due to pricing actions and strategic focus. The company also completed the sale of most of its Kwan Yin properties, using proceeds to reduce debt and improve financial flexibility. Despite a mixed global environment, Chemours maintains its full-year guidance, emphasizing pricing strategies, operational excellence, and leveraging geopolitical conditions.
Chemours Announces Second Quarter Dividend
The Chemours Company announced a quarterly cash dividend of $0.0875 per share for the second quarter of 2026. This dividend will be paid on June 16, 2026, to stockholders of record as of May 17, 2026. Chemours, a global leader in industrial and specialty chemicals, operates through three businesses: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials.
Press Release: The Chemours Company Reports First Quarter Results
NULL
Earnings Flash (CC) The Chemours Company Posts Q1 Adjusted EPS $0.05 per Share, Vs. FactSet Est of $-0.04
The Chemours Company (CC) announced its Q1 adjusted EPS of $0.05 per share, significantly outperforming the FactSet estimate of -$0.04 per share. This positive earnings surprise indicates a stronger financial performance than anticipated by analysts for the quarter.
Chemours to pay 8.75-cent quarterly dividend on June 16
Chemours (NYSE: CC) has announced a quarterly cash dividend of $0.0875 per share for the second quarter of 2026. The dividend is scheduled to be paid on June 16, 2026, to shareholders who are on record as of the close of business on May 17, 2026. The company, a global leader in chemicals, emphasized its commitment to returning value to shareholders through this declaration.
Earnings Flash (CC) The Chemours Company Reports Q1 Revenue $1.38B, vs. FactSet Est of $1.40B
The Chemours Company reported first-quarter revenue of $1.38 billion, falling short of the FactSet estimate of $1.40 billion. The company also posted Q1 Adjusted EPS of $0.05 per share, exceeding the FactSet estimate of $-0.04. This financial update follows several recent analyst target adjustments for Chemours.
Chemours - Thesis Materialization In 2026 (Rating Downgrade) (NYSE:CC)
The article discusses Chemours (CC) which has seen a significant return on investment due to strong growth in its refrigerant segment. Despite this performance, the author has downgraded their rating to 'HOLD/Neutral' because the stock is now trading above their fair value target of $30/share. While fundamentally sound, the company faces risks such as high leverage, regulatory liabilities, and cyclical exposure in its TiO2 market.
Fluoropolymers Market: Asia-Pacific Leads; The Chemours Company, Daikin Industries Ltd. & Solvay S.A. Drive Growth
The global fluoropolymers market is rapidly expanding, projected to reach $30.24 billion by 2036 with a 9.1% CAGR, driven by demand from semiconductor manufacturing and lithium-ion battery production. Asia-Pacific, particularly India, is leading this growth, while regulatory uncertainty surrounding PFAS substances poses a significant challenge. Key players like The Chemours Company, Daikin Industries Ltd., and Solvay S.A. are focused on compliant technologies and application engineering to meet evolving industry needs.
Chemours Co stock hits 52-week high at 27.53 USD By Investing.com
Chemours Co (CC) stock has reached a new 52-week high of $27.53, reflecting a 130% year-to-date return, though InvestingPro's Fair Value analysis suggests it may be overvalued. The company recently completed a $700 million debt offering to redeem existing notes and analysts foresee improved profitability and increased titanium dioxide EBITDA margins.
Chemours Co stock hits 52-week high at 27.53 USD By Investing.com
Chemours Co (CC) stock has reached a 52-week high of $27.53, representing a 130% year-to-date return, driven by strong investor confidence and strategic growth initiatives. Despite InvestingPro's Fair Value analysis suggesting it might be overvalued, analysts predict a return to profitability and net income growth this year. Recent developments include a $700 million debt offering and an "Outperform" rating from RBC Capital due to expected improvements in titanium dioxide EBITDA margins.
How (CC) Movements Inform Risk Allocation Models
This article analyzes Chemours Company (NYSE: CC) using AI models, indicating a strong overweight bias across all time horizons despite elevated downside risk at current levels. It outlines three distinct trading strategies (Position, Momentum Breakout, Risk Hedging) with specific entry, target, and stop-loss parameters, alongside a multi-timeframe signal analysis highlighting support and resistance levels. The analysis aims to help investors optimize position sizing and minimize drawdown risk.
Chemours (NYSE: CC) holders back pay plan, 2026 equity plan and PwC
Chemours Company shareholders approved its 2026 Equity and Incentive Plan, reserving over 6.3 million shares for stock-based awards. Additionally, all eleven director nominees were elected, an advisory say-on-pay vote on executive compensation passed, and PricewaterhouseCoopers LLP was ratified as the independent auditor. These approvals occurred at the company's annual meeting on April 24, 2026.
Chemours Shareholders Approve 2026 Equity Incentive Plan
Chemours Company shareholders approved a new 2026 Equity and Incentive Plan on April 24, 2026, authorizing over 6 million shares for stock-based awards to align incentives with shareholder interests. Investors also re-elected all directors, approved executive pay, and ratified PricewaterhouseCoopers LLP as the independent auditor. An analyst rated CC stock as a Buy with a $30.00 price target, while TipRanks’ AI Analyst, Spark, gave it a Neutral score.
Pekin Hardy Strauss Inc. Has $2.94 Million Holdings in The Chemours Company $CC
Pekin Hardy Strauss Inc. significantly reduced its stake in The Chemours Company (NYSE:CC) by 27.1% in the fourth quarter, now holding 249,153 shares valued at approximately $2.94 million. Despite the institutional sell-off, Chemours reported strong Q4 EPS of $0.05, exceeding expectations, on revenues of $1.33 billion. The stock is currently trading near its 52-week high, offers a 1.4% dividend yield, and holds a consensus "Hold" rating from analysts with an average price target of $20.70.
Assessing Chemours (CC) Valuation After A Strong Multi‑Period Share Price Run
Chemours (CC) has seen significant stock price appreciation recently, with shares up over 24% in the last month and over 115% year-to-date. Despite this surge and a current price of $26.34 against an analyst target of $22.67, Simply Wall St's analysis suggests the stock is overvalued, with a fair value of $16.33, primarily due to future earnings potential and lingering legal risks. However, another view based on multiples suggests a 55.3% discount to intrinsic value, highlighting a split in valuation perspectives due to recent returns and unresolved risks.
Vanguard Capital Management (CC) reports 7.9M shares; 5.26% holding
Vanguard Capital Management has filed a Schedule 13G, disclosing a passive beneficial ownership of 7,903,519 shares of Chemours Co/The (CC), which represents 5.26% of the company's common stock. The filing also indicates that Vanguard has sole dispositive power over all these shares and sole voting power over 1,129,602 shares. This standard disclosure signifies Vanguard's significant but passive investment in Chemours.
Vanguard Portfolio Management reports 10.46M Chemours shares (CC)
Vanguard Portfolio Management has reported beneficial ownership of 10,456,302 shares of Chemours Co (CC) Common Stock as of March 31, 2026, representing 6.96% of the class. This disclosure, made via a Schedule 13G filing signed on April 29, 2026, by Ashley Grim, Head of Global Fund Administration, indicates sole voting power over 130,961 shares and sole dispositive power over all 10,456,302 shares. The shares are held for Vanguard funds and managed accounts, with the filing emphasizing that they were acquired in the ordinary course of business for investment purposes rather than to influence control.
The Chemours Co. Hits New 52-Week High at $26.98
The Chemours Co. reached a new 52-week high of $26.98 on April 27, 2026, marking a significant increase from its previous low of $9.13. Despite this growth, its year-over-year performance of 10.66% lags behind the S&P 500's 29.84%. The specialty chemicals company currently operates at a loss, as indicated by a negative return on equity, and has a market capitalization of USD 3,138 million with a dividend yield of 1.67%.
Cumberland Wants State to Make Chemours Fix Filters, Pay for Public Water
Cumberland County commissioners are urging North Carolina regulators to compel Chemours to adequately address PFAS contamination in Gray's Creek residents' drinking water. They claim Chemours has failed to submit a corrective action plan and properly maintain water filter systems, leading to bacterial growth. The county is also investing in extending public water service to the affected community and wants clarity on Chemours' financial obligations for public water connections and monthly bills.
Chemours (NYSE:CC) Stock Forecast & Analyst Predictions
Chemours (NYSE:CC) is forecast to achieve significant earnings growth of 115.5% and revenue growth of 4.8% per annum. The company's future return on equity is projected to be 55.7% in three years. Recent analyst updates show fluctuating price targets, influenced by factors like cooling technology partnerships, share repurchases, and ongoing PFAS litigation.
The Chemours Co. Hits New 52-Week High at $26.65
The Chemours Co. reached a new 52-week high of $26.65, demonstrating significant stock price appreciation from its low of $9.13. Despite this, the company's one-year performance of 11.2% lags behind the S&P 500's 30.64%. The specialty chemicals firm, with a market capitalization of $3,138 million, is currently loss-making, exhibiting a negative return on equity and a high price-to-book ratio.
